Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem (Myslee) in adolescent insomnia
NCT00653562Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2006
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of zolpidem in Insomnia, sponsored by Astellas Pharma. Primary endpoint: Sleep latency at 2 days. Started Nov 2006; status: completed.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00653562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653562.